Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Alnylam initiates Phase II study of ALN-TTR02
Alnylam initiates Phase II study of ALN-TTR02
Alnylam initiates Phase II study of ALN-TTR02
Submitted by
admin
on June 9, 2012 - 4:42pm
Source:
Pharmaceutical Business Review
News Tags:
Alnylam
ALN-TTR02
amyloidosis
Headline:
Alnylam initiates Phase II study of ALN-TTR02
Do Not Allow Advertisers to Use My Personal information
